Mutual Funds
LIC MF Healthcare Fund-Reg(G)
Equity  |   Very High  |   Equity - Sectoral Fund - Pharma & Health Care
32.46   +0.53
NAV(₹) as on 9/7/2026 		1.64%
  1D 		10.77%
  1Y 		22.01%
  3Y 		10.96%
  5Y
LIC MF Healthcare Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio:
 Launch Date:
28 Feb 2019
Exit Load:
Nil upto 12% of units and 1% for remaining units on or before 90D, Nil after 90D 		AUM:
₹ 92.55 Crs
Lock-in:
Nil 		Investing Style:
Large Growth
Portfolio Price To Book Value:
8.56 		Min. Investment:
SIP : ₹ 200.00
Lumpsum : ₹ 5,000.00
Scheme Benchmark:
NA
Fund Manager:
Sudhanshu Asthana

FUND OBJECTIVE

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

LATEST ASSET & PORTFOLIO ALLOCATION Others Equity
as on 30/6/2026 4.81 % 95.19 %
TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.
10.55 %

Divi's Laboratories Ltd.
7.17 %

Apollo Hospitals Enterprise Ltd.
6.77 %

Torrent Pharmaceuticals Ltd.
6.55 %

Neuland Laboratories Ltd.
5.74 %

Navin Fluorine International Ltd.
5.58 %

Aurobindo Pharma Ltd.
5.30 %

Zydus Lifesciences Ltd.
5.11 %

Fortis Healthcare Ltd.
4.45 %

Gland Pharma Ltd.
3.79 %

See All Holding
ALLOCATION BY MARKET CAP (Equity)
ALLOCATION BY RATING (Debt & Others)

No Data

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs
62.52 %

Hospital & Healthcare Servic
27.09 %

Chemicals
5.58 %

See All Sectors
PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year 2021-22 2022-23 2023-24 2024-25 2025-26
NAV (31/3/2026) 17.99 15.83 23.71 28.27 27.34
Net Assets (Rs Crores) 6,830.34 4,962.17 6,169.03 8,268.95 7,829.92
Scheme Returns(%)(Absolute) 10.37 -12.01 49.49 17.88 -1.74
B'mark Returns(%)(Absolute) NA NA NA NA NA
Category Rank 52/75 72/76 30/90 7/102 57/120
RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details Inception Date Aum(₹ Crs) 1Y 3Y 5Y Since Inception
MDB Logo
Kotak Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.12   +0.26  
11/12/2023 ₹ 678.41 19.40% - - 20.34%
MDB Logo
Quant Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  17.19   +0.26  
17/7/2023 ₹ 391.06 9.39% - - 19.92%
MDB Logo
HDFC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  20.62   +0.31  
4/10/2023 ₹ 2,611.33 20.51% - - 30.09%
MDB Logo
WOC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.13   +0.24  
6/2/2024 ₹ 741.34 18.31% - - 21.81%
MDB Logo
PGIM India Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.50   +0.17  
6/12/2024 ₹ 103.24 15.00% - - 9.19%
MDB Logo
Bajaj Finserv Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.00   +0.15  
27/12/2024 ₹ 354.03 13.00% - - 6.43%
MDB Logo
Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  10.46   +0.12  
27/6/2025 ₹ 553.17 4.28% - - 4.43%
MDB Logo
Bandhan Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  10.86   +0.15  
28/11/2025 ₹ 310.92 - - - 8.64%
MDB Logo
ITI Pharma & Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  17.50   +0.23  
8/11/2021 ₹ 251.87 6.21% 19.28% - 12.73%
MDB Logo
Nippon India Pharma Fund(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  560.38   +4.90  
5/6/2004 ₹ 9,044.23 7.91% 20.78% 12.71% 19.98%